Forrest.
I recently read a comment that CST could capture a third of the Latent TB market.My view with cost being the primary concern which has now been proven to be the opposite with using QFT they are in my view in a position to have a much more significant share than a third.
Why get a dose of rat poison when you can just give a pin prick of blood for a totally more accurate diagnosis.
Another good finish today with holders selling into a trap once more.
Time to realize CST is about to to bust out so why give your scrip away?
Could touch $3.00 this week.With a good quarter result much more.
Regards,
Add to My Watchlist
What is My Watchlist?
